Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma.
Phase of Trial: Phase III
Latest Information Update: 14 Apr 2016
At a glance
- Drugs Octreotide (Primary)
- Indications Liver cancer
- Focus Registrational; Therapeutic Use
- Sponsors Novartis
- 09 Sep 2011 Actual end date added as 1 Mar 2008 as reported by ClinicalTrials.gov.
- 01 Jul 2009 Results published in the European Journal of Cancer.
- 27 Jun 2009 Results were reported at the 11th World Congress on Gastrointestinal Cancer.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History